Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 13/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.43 |
| ▸ | USP7 | Q93009 | 2/20 | 0.41 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27631730 | 1.00 | ESR1 (0.48) | ESR1ESR2FGFR1FGFR2USP7 | |
| SCHEMBL12987550 | 0.78 | ESR1 (0.46) | ESR1ESR2FGFR1FGFR2USP7 | |
| SCHEMBL12892354 | 0.77 | HDAC1 (0.39) | HDAC1HDAC8HDAC6HDAC5 | |
| SCHEMBL29557461 | 0.76 | ESR1 (0.74) | ESR1ESR2FGFR1FGFR2AR | |
| SCHEMBL2862424 | 0.76 | ESR1 (0.74) | ESR1ESR2FGFR1FGFR2AR | |
| SCHEMBL8555801 | 0.74 | RAB9A (0.49) | ESR1USP7 | |
| SCHEMBL14818817 | 0.74 | ESR1 (0.49) | ESR1ESR2FGFR1FGFR2USP7 | |
| SCHEMBL30957336 | 0.74 | MAOB (0.42) | ESR1ESR2 | |
| SCHEMBL9171667 | 0.73 | NR5A1 (0.51) | USP7 | |
| SCHEMBL8520094 | 0.73 | NR5A1 (0.51) | USP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598933-A1 | PHOSPHORAMIDATE COMPOUNDS AND USES THEREOF | Allorion Therapeutics Inc (US) | 2025-08-13 | — | — | EP | disclosed |
| CN-119968377-A | Phosphoramidate compounds and uses thereof | 安锐生物医药公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024078392-A1 | PHOSPHORAMIDATE COMPOUNDS AND USES THEREOF | ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) | 2024-04-18 | — | — | WO | disclosed |